Boehringer’s Humira biosimilar wins US green light

30th August 2017 Uncategorised 0

US regulators have approved Boehringer Ingelheim’s Cyltezo, a biosimilar to AbbVie’s Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases.

More: Boehringer’s Humira biosimilar wins US green light
Source: News